E.I. du Pont de Nemours & Co (DD)

73.31
0.34 0.47
NYSE : Basic Materials
Prev Close 72.97
Open 73.05
Day Low/High 72.62 / 73.59
52 Wk Low/High 50.71 / 75.86
Volume 654.62K
Avg Volume 2.85M
Exchange NYSE
Shares Outstanding 869.34M
Market Cap 63.98B
EPS 2.20
P/E Ratio 31.72
Div & Yield 1.52 (2.10%)

Latest News

Allergan, Schlumberger, IBM: Doug Kass' Views

Allergan, Schlumberger, IBM: Doug Kass' Views

Doug Kass shares his thoughts on animal spirits, and discusses his astonishment at some rising optimism.

No, Shockingly Altaba Isn't the Dumbest Corporate Name Ever Created

No, Shockingly Altaba Isn't the Dumbest Corporate Name Ever Created

What were these places thinking?

S&P 500 Rises on Strength in Financial Stocks, Dow Slips

S&P 500 Rises on Strength in Financial Stocks, Dow Slips

The S&P 500 moves higher on Friday as financials benefit from better-than-expected earnings from Bank of America and JPMorgan Chase.

Dow-DuPont Merger Outcome 'Still Very Open,' Says EU Commissioner

Dow-DuPont Merger Outcome 'Still Very Open,' Says EU Commissioner

European competition commissioner Margarethe Vestager is still looking into the planned merger of agrochemical companies Dow and DuPont.

Allergan, Google, Oaktree Capital: Doug Kass' Views

Allergan, Google, Oaktree Capital: Doug Kass' Views

Doug Kass shares his thoughts on how January has a lot of nonsense, and reviews his investment troops.

Alphabet, Apple, Allergan: Doug Kass' Views

Alphabet, Apple, Allergan: Doug Kass' Views

Doug Kass shares his thoughts on the deepening of retail stocks' weakness and the Amazon Effect.

Craft a Strategy From Retail's Wreckage: Best of Kass

Craft a Strategy From Retail's Wreckage: Best of Kass

In highlights from this week's trading diary and posts, Kass tells us about how the market's optimism is misplaced and how to make a strategy from retail's wreckage.

Novice Trade: XLB

Novice Trade: XLB

This is a high-risk trade. Use only highly discretionary capital.

Apple, Allergan, Kohl's: Doug Kass' Views

Apple, Allergan, Kohl's: Doug Kass' Views

Doug Kass shares his thoughts on what was good, bad and ugly in this short, last week of the year.

Allergan, Apple, Costco: Doug Kass' Views

Allergan, Apple, Costco: Doug Kass' Views

Doug Kass shares his thoughts on the post-fact investment world and delivers his verdict on Caterpillar.

Apple, Alphabet, Starbucks: Doug Kass' Views

Apple, Alphabet, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on divergences in the market's armor and observes that real tech regulation is complicated.

Allergan, Apple, Oakland Capital: Doug Kass' Views

Allergan, Apple, Oakland Capital: Doug Kass' Views

Doug Kass shares his thoughts on China and life insurers.

Jim Cramer's 'Mad Money' Recap: Sloppiness Causing Investors to Lose Focus

Jim Cramer's 'Mad Money' Recap: Sloppiness Causing Investors to Lose Focus

Jim Cramer tells people to stay informed and stay focused on next week's game plan.

Cramer: A Road Map for 'Dow 20,000'

Cramer: A Road Map for 'Dow 20,000'

This number is arbitrary, but for those who have latched onto it, here is a possible scenario that could get us there.

Hygiena To Acquire Food Safety Diagnostics Business From DuPont

Hygiena To Acquire Food Safety Diagnostics Business From DuPont

Leading microbiology and life sciences company to combine with global microbial detection and diagnostics business

Apple, Amazon, Cisco: Doug Kass' Views

Apple, Amazon, Cisco: Doug Kass' Views

Doug Kass shares his thoughts on how volatility is now underpriced.

Facebook, Apple, Starbucks: Doug Kass' Views

Facebook, Apple, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on managing and selecting short-term trades.

Stocks Lose Highs, Dow Still on Track For Record

Stocks Lose Highs, Dow Still on Track For Record

Wall Street is on track to smash closing records on Thursday as a broad rally among stocks resumes.

DuPont's Drift Down Is An Opportunity

DuPont's Drift Down Is An Opportunity

Patient investors should consider a decline to $71 or $70 as a low-risk entry point.

Apple, Starbucks, Cisco: Doug Kass' Views

Apple, Starbucks, Cisco: Doug Kass' Views

Doug Kass shares his thoughts on a strange, possibly ominous day, and a 'ludicrous forecast.'

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer's 'Mad Money' Recap: Investors See Washington Going Pro-Business

Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.

DuPont: The Sweet Buy and Buy

DuPont: The Sweet Buy and Buy

What are you waiting for? Prices are breaking out on the upside.

Home Depot, Lowe's, Best Buy: Doug Kass' Views

Home Depot, Lowe's, Best Buy: Doug Kass' Views

Doug Kass shares his thoughts on the Trump world and how large-cap biotechs are doing.

Starbucks, Facebook, Apple: Doug Kass' Views

Starbucks, Facebook, Apple: Doug Kass' Views

Doug Kass shares his thoughts on how faster growth won't be easy and how the debt and deficits are out of control.

Facebook, Home Depot, Disney: Doug Kass' Views

Facebook, Home Depot, Disney: Doug Kass' Views

Doug Kass shares his thoughts on contrariness and his takeaways and observations on the market.

Dow Chemical a Good Investment, With or Without the DuPont Merger

Dow Chemical a Good Investment, With or Without the DuPont Merger

European and U.S. regulators must still approve of the deal between two of the world's three biggest companies.

Allergan, Macy's, Apple: Doug Kass' Views

Allergan, Macy's, Apple: Doug Kass' Views

Doug Kass shares his thoughts on closed-end municipal bond funds.